News Stemtech Corporation

Stocks

STEK

US85859W1027

Pharmaceuticals

Delayed OTC Markets Other stock markets 12:49:43 2026-07-23 EDT			5-day change	1st Jan Change
0.000100 ^USD	+9,900.00%		-99.00%	-87.50%

06-22	Stemtech Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-29	Stemtech Corporation Reports Earnings Results for the Full Year Ended December 31, 2025	CI

All News

Mentions Relevance

07-01	Stemtech Corporation Declares July 2026 "Cellular Health Awareness Month"	AQ
06-22	Stemtech Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-29	Stemtech Corporation Reports Earnings Results for the Full Year Ended December 31, 2025	CI
05-28	Stemtech Corporation Auditor Raises 'Going Concern' Doubt	CI
04-07	Stemtech Secures Inventory Funding	AQ
03-18	Stemtech Revolution 2026: A Bold New Era In Global Wellness	AQ
01-06	Stemtech Corporation Appoints Dr. Lizette Leos, MD as Chief Scientific Officer	CI
11-19	Stemtech Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
25-08-19	Stemtech Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
25-07-17	Stemtech Corporation Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
25-06-30	Stemtech Corporation Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25-06-29	Stemtech Corporation Auditor Raises 'Going Concern' Doubt	CI
25-04-14	Stemtech Corporation Announces CFO Changes	CI
25-02-19	Stemtech Corporation, Leading the Global Wellness, Anti-Aging Healthy Revolution	AQ
24-12-11	Stemtech Corporation cancelled the acquisition of Eevia Health Oyj in a reverse merger transaction.	CI
24-12-06	Stemtech : and Seacret Direct / Viago Execute Merger Agreement Form 8 K	PU
24-12-01	Stemtech Corporation signed a letter of intent to acquire Eevia Health Oyj in a reverse merger transaction.	CI
24-11-19	Stemtech Corporation entered into an agreement in principle to acquire SEACRET Direct, LLC for transaction valued at $32.5 million.	CI
24-11-19	Stemtech Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
24-09-26	Stemtech Corporation Sets Strategic Guidance and Expands into $303 Billion Pet Health Market	CI
24-08-27	Stemtech Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
24-08-23	Stemtech Expands Into the $303 Billion Pet Health Care Market with Launch of Stempets	AQ
24-08-22	Stemtech Corporation Announces the Launch of StemPets	CI
24-07-16	Stemtech Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
24-07-10	Stemtech Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI